Combination targeted treatment produces lasting remissions in people with resistant aggressive B-cell lymphoma Combination therapy developed by NIH researchers demonstrates the power of precision medicine.

https://www.nih.gov/news-events/news-releases/combination-targeted-treatment-produces-lasting-remissions-people-resistant-aggressive-b-cell-lymphoma